Vicarious Surgical Inc (NYSE:RBOT) Sees Significant Decline in Short Interest

Vicarious Surgical Inc (NYSE:RBOT) saw a large decrease in short interest in the month of June. As of June 15th, there was short interest totalling 179,600 shares, a decrease of 96.3% from the May 31st total of 4,840,000 shares. Based on an average daily volume of 19,900 shares, the days-to-cover ratio is currently 9.0 days.

Vicarious Surgical Stock Performance

RBOT opened at $5.85 on Friday. The business’s 50-day simple moving average is $9.02 and its 200-day simple moving average is $10.52. The company has a market cap of $34.36 million, a P/E ratio of -0.51 and a beta of 1.21. Vicarious Surgical has a one year low of $5.41 and a one year high of $62.10.

Vicarious Surgical (NYSE:RBOT) last released its quarterly earnings results on Monday, April 29th. The company reported ($2.70) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($3.00) by $0.30. As a group, analysts predict that Vicarious Surgical will post -10.91 earnings per share for the current fiscal year.

Institutional Trading of Vicarious Surgical

A number of hedge funds have recently added to or reduced their stakes in RBOT. SRS Capital Advisors Inc. lifted its position in Vicarious Surgical by 215.0% during the 4th quarter. SRS Capital Advisors Inc. now owns 87,905 shares of the company’s stock worth $32,000 after acquiring an additional 60,000 shares during the period. Hudson Bay Capital Management LP acquired a new stake in Vicarious Surgical during the 3rd quarter worth approximately $207,000. Seven Grand Managers LLC acquired a new stake in shares of Vicarious Surgical in the 3rd quarter valued at approximately $295,000. Regal Partners Ltd acquired a new stake in shares of Vicarious Surgical in the 3rd quarter valued at approximately $390,000. Finally, Element Capital Management LLC acquired a new stake in shares of Vicarious Surgical in the 3rd quarter valued at approximately $585,000. 47.27% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Piper Sandler cut their price target on Vicarious Surgical from $45.00 to $30.00 and set a “neutral” rating on the stock in a report on Tuesday, March 5th.

About Vicarious Surgical

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.